Freeman Hrabowski Scholar, Howard Hughes Medical Institute
Assistant Professor of Pathology, Microbiology & Immunology
Vanderbilt University Medical Center
Lab website: https://www.vumc.org/byndloss-lab/byndloss-laboratory
Mariana Byndloss received her D.V.M. and a Ph.D. from Universidade Federal de Minas Gerais in Brazil. After completing her postdoctoral fellowship at the University of California, Davis, Mariana started her lab in the Department of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center in 2018. Her research aims at understanding how disruption in beneficial microbiota-intestinal epithelium metabolic interactions increase risk of noncommunicable diseases, namely obesity and obesity-associated cardiovascular disease and colon cancer. Additionally, Mariana is interested in understanding whether changes in the gut microbiota due to early life exposure to environmental risk factors (e.g., western-style diet or antibiotics) causes early-onset colorectal cancer. Mariana has authored over 70 scientific publications, including some in high-impact journals such as Nature and Science, and has been named a Clarivate highly cited researcher in 2021 and 2022. She is a HHMI Freeman Hrabowski Scholar and has received multiple awards throughout her career, including the Science NOSTER Microbiome Prize (runner-up), a V Scholar Award (from V Foundation of Cancer Research), a Pew Biomedical Scholar Award (from the Pew Charitable Trusts), and a Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease Award.